Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 + Vacuum Therapy in Peyronie's Disease
NCT02267460Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Oct 2014
- Primary completion
- Oct 2015
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of collagenase clostridium histolyticum in Peyronie's disease, sponsored by Endo International plc. Started Oct 2014; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Peyronie's disease
Beyond the preview
Go deeper on NCT02267460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267460.